We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$2.85B
AUM Growth
+$169M
Cap. Flow
+$16.4M
Cap. Flow %
0.58%
Top 10 Hldgs %
65.16%
Holding
451
New
10
Increased
153
Reduced
16
Closed
14

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$5.11M
2
LMND icon
Lemonade
LMND
+$4.4M
3
TTD icon
Trade Desk
TTD
+$3.52M
4
BSX icon
Boston Scientific
BSX
+$2.93M
5
TRP icon
TC Energy
TRP
+$2.69M

Top Sells

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$25M
2
LLY icon
Eli Lilly
LLY
+$4.8M
3
STAA icon
STAAR Surgical
STAA
+$1.43M
4
BPMC
Blueprint Medicines
BPMC
+$1.12M
5
TCP
TC Pipelines LP
TCP
+$337K

Sector Composition

Rank Sector Weight
1 Healthcare 46.71%
2 Consumer Discretionary 8.55%
3 Technology 8.03%
4 Communication Services 7.66%
5 Financials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEAM icon
326
Beam Therapeutics
BEAM
$2.63B
$65K ﹤0.01%
806
– –
ALXN
327
DELISTED
Alexion Pharmaceuticals
ALXN
$65K ﹤0.01%
424
– –
VNQ icon
328
Vanguard Real Estate ETF
VNQ
$39.2B
$64K ﹤0.01%
697
+185
+36% +$16.3K
PANW icon
329
Palo Alto Networks
PANW
$270B
$63K ﹤0.01%
1,182
-6
-0.5% -$357
C icon
330
Citigroup
C
$222B
$62K ﹤0.01%
851
+1
+0.1% +$67
SLB icon
331
SLB Ltd
SLB
$73.6B
$60K ﹤0.01%
2,218
– –
ACA icon
332
Arcosa
ACA
$7.13B
$59K ﹤0.01%
900
– –
NTLA icon
333
Intellia Therapeutics
NTLA
$1.49B
$59K ﹤0.01%
734
– –
SCHW
334
Charles Schwab
SCHW
$183B
$59K ﹤0.01%
908
– –
D icon
335
Dominion Energy
D
$60.8B
$58K ﹤0.01%
762
+5
+0.7% +$363
EGP icon
336
EastGroup Properties
EGP
$11.2B
$58K ﹤0.01%
405
– –
MEI icon
337
Methode Electronics
MEI
$496M
$58K ﹤0.01%
1,380
– –
VRRM icon
338
Verra Mobility
VRRM
$804M
$58K ﹤0.01%
4,310
– –
CMCO icon
339
Columbus McKinnon
CMCO
$553M
$57K ﹤0.01%
1,085
– –
CTG
340
DELISTED
Computer Task Group, Inc.
CTG
$56K ﹤0.01%
5,877
– –
GE icon
341
GE Aerospace
GE
$374B
$54K ﹤0.01%
828
– –
KALU icon
342
Kaiser Aluminum
KALU
$2.61B
$54K ﹤0.01%
490
– –
MKSI icon
343
MKS Inc
MKSI
$20.1B
$53K ﹤0.01%
285
– –
MGY icon
344
Magnolia Oil & Gas
MGY
$6.09B
$52K ﹤0.01%
4,540
– –
VEA icon
345
Vanguard FTSE Developed Markets ETF
VEA
$229B
$52K ﹤0.01%
1,063
+5
+0.5% +$244
SPLK
346
DELISTED
Splunk Inc
SPLK
$52K ﹤0.01%
385
– –
MGEE icon
347
MGE Energy Inc
MGEE
$3B
$51K ﹤0.01%
715
– –
RYAAY icon
348
Ryanair
RYAAY
$30.4B
$51K ﹤0.01%
1,115
– –
CRI icon
349
Carter's
CRI
$1.42B
$50K ﹤0.01%
560
– –
PNR icon
350
Pentair
PNR
$10.4B
$50K ﹤0.01%
806
– –
12 13
14
15 16

Similar funds

OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return

Bollard Group's Q1 2021 Portfolio in Review

As of Q1 2021, Bollard Group held 451 positions worth $2.85B, up 6.3% from $2.69B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Bollard Group's Q1 2021 filing shows 10 new, 153 increased, 16 reduced and 14 closed positions. Its largest new stake was Lemonade: 34,100 shares worth $3.18M. The largest sale was DraftKings, an estimated $25M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bollard Group's largest Q1 2021 buy was Lemonade: 34,100 shares worth $3.18M.
  • Bollard Group added most to Gartner in Q1 2021, an estimated $5.11M increase.
  • Bollard Group's biggest Q1 2021 reduction was Eli Lilly, cutting an estimated $4.8M.
  • Bollard Group fully exited DraftKings in Q1 2021, selling an estimated $25M.
  • Bollard Group's ten largest holdings make up 65% of its $2.85B portfolio in Q1 2021.
  • Bollard Group opened 10 new positions and closed 14 in Q1 2021.
  • Bollard Group's portfolio value rose 6.3% quarter-over-quarter to $2.85B.

Based on Bollard Group's 13F filing for Q1 2021, filed 11 May 2021.